CompBrief BY VELARION

Companies Evolent Health

Evolent Health (EVH): executive pay, fiscal 2025

Free brief. Every figure links to the company’s own filing.

Velarion Intel: free for 3 days, no card →

Email me Evolent Health’s executive pay brief as a PDF

You get it on this page the moment you ask, and a copy by email. Every figure is cited to its filing.

After the PDF, up to three short notes on the deeper reports for this company. Reply “unsubscribe” to any of them, any time.

Also free: The Pay Desk, the weekly executive pay briefing.
CEO total pay$14,240,154CEO Seth Blackley · source
Say-on-pay support88.05%Latest vote · source
CEO vs. named peers88th pct.Of 17 peer CEOs
CEO pay ratio192.6:1To the median employee · source

CEO pay, last three years

  • $8,931,188FY2023
  • $11,136,185FY2024
  • $14,240,154FY2025

CEO total pay was $14,240,154 in fiscal 2025, up from $11,136,185 in fiscal 2024.

FY2025: salary $867,068 · bonus $660,000 · stock awards $12,699,086 · option awards $0

Executives and directors

Emily Rafferty · EVPJonathan Weinberg · General CounselDaniel McCarthy · PresidentSeth Blackley · CEOJohn Johnson · ExecutiveBrendan Springstubb · Independent DirectorCheryl Scott · Former director (through FY2025)Craig Barbarosh · Independent DirectorDiane Holder · Independent DirectorJill Smith · Independent DirectorKim Keck · Independent DirectorM. Bridget Duffy, MD · Former director (through FY2025)Peter Grua · Independent DirectorRichard Jelinek · Chair of the BoardRussell Glass · Independent DirectorShawn Guertin · Independent DirectorToyin Ajayi, MD · Independent Director

Frequently asked questions

Who was the highest-paid executive at Evolent Health in fiscal 2025?
As disclosed, Seth Blackley (Chief Executive Officer) was the highest-paid executive at Evolent Health in fiscal 2025, with total compensation of $14,240,154.
How does Evolent Health's chief executive pay compare to its disclosed peer group?
As disclosed, Seth Blackley's total compensation ranked at the 88th percentile of Evolent Health's disclosed peer group.
What is Evolent Health's CEO-to-median employee pay ratio?
As disclosed, Evolent Health's CEO-to-median employee pay ratio was 192.6:1.
How did shareholders vote on Evolent Health's executive compensation?
As disclosed, 88.05% of shareholders supported Evolent Health's executive compensation in the latest say-on-pay vote.
How much does Evolent Health spend in total on board compensation for fiscal 2025?
As disclosed, Evolent Health reported total board compensation of $2,763,417 for fiscal 2025.

Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.

Full detail

Every table from the filing. Open any section.

Summary compensation table
Named executive officerSalaryBonusStock awardsOption awardsNon-equity incentivePension / NQDCAll otherTotal
Seth Blackley$867,068$660,000$12,699,086$0$0$0$14,000$14,240,154
Chief Executive Officer
Daniel McCarthy650,301495,0008,466,06300011,9159,623,279
President
John Johnson541,91804,815,03200013,7215,370,671
Former Chief Financial Officer; Chief Strategy Officer
Jonathan Weinberg460,360262,9691,902,33500014,0002,639,664
General Counsel
Emily Rafferty454,342277,1711,659,33100013,7812,404,625
Former Chief Operating Officer; EVP, Customer Success

A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.

Three-year trend — total compensation per named executive

Named executive officerFY2025 totalFY2024 totalFY2023 totalΔ FY2024→2025
Seth Blackley$14,240,154$11,136,185$8,931,188↑ +3,103,969
Daniel McCarthy9,623,2797,484,9235,763,625↑ +2,138,356
John Johnson5,370,6714,814,2913,530,596↑ +556,380
Jonathan Weinberg2,639,6641,966,4492,012,894↑ +673,215
Emily Rafferty2,404,6252,009,2122,291,560↑ +395,413

Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.

Incentive-plan design — the Compensation Discussion & Analysis

The Company's executive compensation programs strongly align realized compensation outcomes with the Company's stock price performance.

CEO STI target (% of salary)100%
CEO LTI target (% of salary)—
Independent consultantExequity
Clawback policytrue
Anti-hedgingtrue
Anti-pledgingtrue
Equity grants and outstanding awards

Grants of plan-based awards — fiscal year 2025

ExecutiveAwardGrant dateThresholdTargetGrantedMaximumGrant-date fair value
Seth BlackleyPSU2025-03-03352,538705,076—1,762,690$9,856,962
Jonathan WeinbergPSU2025-03-0337,77275,543—75,5431,056,091
Jonathan WeinbergRSU2025-03-03——65,470—574,172
Emily RaffertyRSU2025-03-03——72,937—639,657
Emily RaffertyPSU2025-03-0336,46972,938—182,3451,019,673
Daniel McCarthyPSU2025-03-03235,026470,051—1,175,1286,571,313
John JohnsonPSU2025-03-03133,670267,339—668,3483,737,399
Jonathan WeinbergRSU2025-07-01——23,394—272,072
Daniel McCarthyRSU2025-03-03——156,683—1,374,110
John JohnsonRSU2025-03-03——89,113—781,521
Daniel McCarthyRSU2025-07-01——44,767—520,640
John JohnsonRSU2025-07-01——25,461—296,111

Vehicle mix — grant-date fair value by award type

Named executive officerTime-vested (RSU)Performance-vested (PSU)Options / SARs% performance-vested
Seth Blackley$0$9,856,962$0100.0%
Jonathan Weinberg846,2441,056,091055.5%
Emily Rafferty639,6571,019,673061.5%
Daniel McCarthy1,894,7506,571,313077.6%
John Johnson1,077,6323,737,399077.6%

% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.

Outstanding equity awards at fiscal year-end 2025

ExecutiveAwardShares unvestedExercise priceMarket value unvested
Jonathan WeinbergRSU4,210—$16,840
Emily RaffertyRSU5,775—23,100
John JohnsonRSU6,736—26,944
Emily RaffertyRSU7,201—28,804
John JohnsonRSU8,001—32,004
Daniel McCarthyRSU9,094—36,376
Daniel McCarthyRSU12,802—51,208
Jonathan WeinbergRSU14,402—57,608
Jonathan WeinbergRSU15,821—63,284
Seth BlackleyRSU19,203—76,812
Seth BlackleyRSU19,471—77,884
Jonathan WeinbergRSU23,394—93,576
Emily RaffertyRSU23,731—94,926
John JohnsonRSU25,461—101,844
Daniel McCarthyRSU44,767—179,068
Jonathan WeinbergRSU65,470—261,880
Seth BlackleyRSU67,150—268,600
Emily RaffertyRSU72,937—291,748
Emily RaffertyRSU72,938—291,752
Jonathan WeinbergRSU75,543—302,172
John JohnsonRSU79,105—316,422
John JohnsonRSU89,113—356,452
Daniel McCarthyRSU126,569—506,276
Daniel McCarthyRSU156,683—626,732
Seth BlackleyRSU189,854—759,417
Seth BlackleyRSU235,025—940,100
John JohnsonRSU267,339—1,069,356
Daniel McCarthyRSU470,051—1,880,204
Seth BlackleyRSU705,076—2,820,304
Director compensation
DirectorCash feesStock awardsOption awardsNon-equity incentiveAll otherTotal
Richard JelinekIndependent · Board Chair · Compensation · Nominating and Governance (Chair) · Strategy$245,000$180,000$0$0$0$425,000
Brendan SpringstubbIndependent · Audit · Compensation · Strategy · Newly elected133,417240,000000373,417
Kim KeckIndependent · Audit (Chair) · Nominating and Governance112,500180,000000292,500
Craig BarbaroshIndependent · Compliance and Regulatory Affairs · Strategy (Chair)102,500180,000000282,500
Toyin Ajayi, MDIndependent · Compensation (Chair) · Nominating/Governance102,500180,000000282,500
Cheryl ScottIndependent · Departed during FY102,500180,000000282,500
Peter GruaIndependent · Compensation (Chair)100,000180,000000280,000
Russell GlassIndependent · Nominating and Governance · Compliance and Regulatory Affairs95,000180,000000275,000
Shawn GuertinIndependent · Audit90,000180,000000270,000
M. Bridget Duffy, MDIndependent · Departed during FY000000
Seth BlackleyEmployee director000—00
Diane HolderIndependent · Not standing for re-election000000
Jill SmithIndependent · Partial-year service · Newly elected000000

Board fee structure and ownership guideline

Annual cash retainer$75,000
Annual equity retainer$160,000
Per board meeting fee—
Committee chair fees (audit / comp / nom-gov)25,000 / 20,000 / 15,000
Stock ownership guideline5 times annual cash retainer

Total cost of the board

ComponentFY2025
Cash retainers and fees$1,083,417
Equity awards (grant-date value)$1,680,000
All other compensation$0
Total cost of the board$2,763,417

Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.

Peer group, and who names Evolent Health as a peer

Companies that benchmark against EVH

16 companies name EVH as a compensation peer

Each company listed discloses EVH in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named EVH in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.

Disclosed peer group — fiscal year 2025

The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.

AMED Amedisys, Inc.PINC Premier, Inc.RCM R1 RCM Inc.OPCH Option Care Health, Inc.OSCR Oscar Health, Inc.RDNT RadNet, Inc.HQY HealthEquity, Inc.ASTH Astrana Health, Inc.AGL agilon Health, Inc.MD Pediatrix Medical Group, Inc.AMN AMN Healthcare Services, Inc.CRVL CorVel CorporationSGRY Surgery Partners, Inc.MANH Manhattan Associates, Inc.TDOC Teladoc Health, Inc.OMCL Omnicell, Inc.VEEV Veeva Systems, Inc.

Peer reciprocity

Of the companies Evolent Health names as compensation peers, which name it back in their own disclosed peer groups. A peer set the market reciprocates reads differently from one selected in a single direction.

Amedisys, Inc. (AMED)✓ Premier, Inc. (PINC)72— R1 RCM Inc. (RCM)73— Option Care Health, Inc. (OPCH)74— Oscar Health, Inc. (OSCR)75— RadNet, Inc. (RDNT)76✓ HealthEquity, Inc. (HQY)77 Astrana Health, Inc. (ASTH)✓ agilon Health, Inc. (AGL)78 Pediatrix Medical Group, Inc. (MD)✓ AMN Healthcare Services, Inc. (AMN)79— CorVel Corporation (CRVL)80— Surgery Partners, Inc. (SGRY)81— Manhattan Associates, Inc. (MANH)82✓ Teladoc Health, Inc. (TDOC)83✓ Omnicell, Inc. (OMCL)84— Veeva Systems, Inc. (VEEV)85

Reciprocity shown where the peer’s own current proxy has been read — each mark is cited in the register to that peer’s filing. A dash means the peer’s current proxy was read and names no reciprocal group including Evolent Health.

Chief executive pay against the peer group

Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company’s own proxy statement.

RankCompanyFYChief executiveSalaryStock awardsOption awardsNon-equity incentiveTotal
1Manhattan Associates, Inc.2025Eric Clark$710,000$13,000,328$0$835,375$16,697,528
2Astrana Health, Inc.2025Brandon Sim850,00011,999,98002,059,12514,930,231
3Evolent Health2025Seth Blackley867,06812,699,0860014,240,154
4R1 RCM Inc.2023Lee Rivas900,00012,240,02101,015,20014,159,376
5Pediatrix Medical Group, Inc.2025Mark Ordan970,0148,456,02402,700,00014,140,217
6HealthEquity, Inc.2026Scott Cutler775,00012,038,5630767,25013,582,105
7RadNet, Inc.2025Howard Berger3,000,0008,999,9660012,087,934
8Premier, Inc.2024Michael Alkire1,095,8768,500,03901,800,15011,806,381
9Teladoc Health, Inc.2025Charles Divita, III800,0009,699,9960584,00011,202,996
10AMN Healthcare Services, Inc.2025Cary Grace1,060,0008,363,11701,146,12510,669,780
11Option Care Health, Inc.2025John Rademacher1,000,0006,500,05001,665,0009,266,330
12Omnicell, Inc.2025Randall Lipps846,8915,219,57601,411,4857,531,852
13Surgery Partners, Inc.2025J. Eric Evans1,050,0005,000,000006,083,862
14agilon Health, Inc.2025Jeffrey Schwaneke625,0002,950,0031,750,000271,8755,610,878
15CorVel Corporation2026Michael Combs679,3270101,716498,8091,285,043
16Oscar Health, Inc.2025Mark Bertolini619,17800169,0361,149,308
17Veeva Systems, Inc.2026Peter Gassner470,833000470,833
—Amedisys, Inc.——————not in coverage universe

Each peer’s compensation is from its most recently filed proxy; fiscal years differ by company. Each peer’s figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.

Incentive design against the same peers

CompanyAnnual incentive payoutLong-term vehicle mixPSU measures include TSRCompensation consultant
Evolent Health75%PSU 70 · RSU 30NoExequity
agilon Health, Inc.58%not disclosedNoSemler Brossy
Amedisys, Inc.not disclosednot disclosednot disclosednot disclosed
AMN Healthcare Services, Inc.87%not disclosedYes — Relative TSRFW Cook
Astrana Health, Inc.193.8%PSU 67 · RSU 33NoPearl Meyer
CorVel CorporationCEO: 75%, EVP Risk: 61%, CIO: 49%, VP Accounting: 28%%not disclosedNonot disclosed
HealthEquity, Inc.99%PSU 60 · RSU 40YesSemler Brossy
Manhattan Associates, Inc.118%RSU 50 · PSU 50NoWillis Towers Watson
Omnicell, Inc.133.3%RSU 50 · PSU 50NoExequity
Option Care Health, Inc.111%PSU 60 · RSU 40NoPearl Meyer
Oscar Health, Inc.91.0%RSU 50 · PSU 50Yes — Relative TSRFW Cook
Pediatrix Medical Group, Inc.180%RSU 50 · PSU 50NoSemler Brossy Consulting Group
Premier, Inc.109.1%PSU 60 · RSU 40NoMercer
R1 RCM Inc.94%PSU 75 · RSU 25NoSullivanCotter
RadNet, Inc.not disclosedRSU 100NoPearl Meyer
Surgery Partners, Inc.not disclosedPSU 60 · Restricted Stock 40NoFrederic W. Cook & Co., Inc. (FW Cook)
Teladoc Health, Inc.73%RSU 50 · PSU 50NoAon
Veeva Systems, Inc.not disclosedOptions 100not disclosedCompensia

Read from each company’s Compensation Discussion and Analysis: annual incentive payout as a percentage of target, the disclosed long-term vehicle mix, whether performance-share measures include a total shareholder return component, and the retained compensation consultant. “Not disclosed” appears only where the company’s filing does not state the item.

Say-on-pay history and pay ratio
Meeting yearMeeting dateForAgainstAbstainSupportOutcome
20262026-06-0458,369,4737,922,80284,11988.05%Passed
20252025-06-0577,588,03110,172,695103,59688.41%Passed
20242024-06-0697,716,1715,954,63926,09694.26%Passed
20232023-06-0898,899,8141,875,30551,30598.14%Passed
20222022-06-0977,483,4022,838,76349,64196.47%Passed
20212021-06-1074,996,027273,42377,85299.64%Passed

Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year’s compensation.

Say-on-pay — history, company’s computation

Meeting yearMeeting dateApproval — company’s computation
20262026-06-0488.05%a
20252025-06-0588.41%b
20242024-06-0694.26%c

a. Approved under the standard stated in the filing — “Proxy Statement 2026 75 Table of Contents Questions and Answers About the Annual Meeting What vote is required to approve each proposal? Proposal Stockholder Vote Required for Approval Effect of Abstentions Effect of Broker Non-Votes (1) 1 Election of Directors Majority of votes cast No effect No effect 2 Ratification of the selection of Deloitte & Touche LLP as our independent public accounting firm Majority of votes cast No effect There will be no broker non-votes 3 Advisory vote to approve executive compensation (2) Majority of votes cast No effect No effect 4 Approval of the Amendment to the Amended and Restated 2015 Omnibus Incentive Compensation Plan Majority of votes cast No effect No effect (1) A "broker non-vote" occurs when a broker holding shares for a street name holder submits a valid proxy but does not vote on a particular proposal because the broker has not received voting instructions from the stockholder for whom it is holding shares and does not have discretionary authority to vote on the matter.”.

b. Approved under the standard stated in the filing — “Proxy Statement 2025 73 Table of Contents Questions and Answers About the Annual Meeting What vote is required to approve each proposal? Proposal Stockholder Vote Required for Approval Effect of Abstentions Effect of Broker Non-Votes (1) 1 Election of Directors Majority of votes cast No effect No effect 2 Ratification of the selection of Deloitte & Touche LLP as our independent public accounting firm Majority of votes cast No effect There will be no broker non-votes 3 Advisory vote to approve executive compensation (2) Majority of votes cast No effect No effect 4 Approval of the Amendment to the Amended and Restated 2015 Omnibus Incentive Compensation Plan Majority of votes cast No effect No effect (1) A "broker non-vote" occurs when a broker holding shares for a street name holder submits a valid proxy but does not vote on a particular proposal because the broker has not received voting instructions from the stockholder for whom it is holding shares and does not have discretionary authority to vote on the matter.”.

c. Approved under the standard stated in the filing — “Abstentions will have no effect on this proposal.”.

Approval percentages are the company’s own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.

CEO pay ratio

Ratio (CEO : median employee)192.6 : 1
CEO total compensation$14,257,351
Median employee compensation$74,011
Insider trades since the proxy

Every insider equity transaction reported on Form 4 after the 2025 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.

InsiderRoleTransaction dateCodeSharesPriceValueSecuritySource
Brendan SpringstubbDirector2026-06-04A41,096$0$0CommonForm 4 ↗
Jill SmithDirector2026-06-04A41,09600CommonForm 4 ↗
Kim KeckDirector2026-06-04A41,09600CommonForm 4 ↗
Richard JelinekDirector2026-06-04A41,09600CommonForm 4 ↗
Shawn GuertinDirector2026-06-04A41,09600CommonForm 4 ↗
Peter GruaDirector2026-06-04A41,09600CommonForm 4 ↗
Toyin Ajayi, MDDirector2026-06-04A41,09600CommonForm 4 ↗
Craig BarbaroshDirector2026-06-04A41,09600CommonForm 4 ↗
Russell GlassDirector2026-06-04A41,09600CommonForm 4 ↗
Aammaad ShamsChief Accounting Officer2026-07-01A28,79000CommonForm 4 ↗
Daniel McCarthyPresident2026-07-01D4,582626,301CommonForm 4 ↗
Jonathan WeinbergGeneral Counsel2026-07-01D2,650615,211CommonForm 4 ↗
Seth BlackleyDirector2026-07-01D10,297659,105CommonForm 4 ↗
Daniel McCarthyPresident2026-07-01A302,58500CommonForm 4 ↗
Jonathan WeinbergGeneral Counsel2026-07-01A43,05500CommonForm 4 ↗
Seth BlackleyDirector2026-07-01A446,10200CommonForm 4 ↗
Daniel McCarthyPresident2026-08-26D65,8925329,460CommonForm 4 ↗

Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.

Sources (85 citations)

Each figure is listed with the filing it comes from, where it appears in that filing, and the value as printed. Any figure can be independently confirmed against the source.

  • Section 01, Seth Blackley. DEF 14A, filed 2026-04-24. Section “Summary Compensation Table” · page 48. As printed: 14,240,154. View filing ↗
  • Section 01, Daniel McCarthy. DEF 14A, filed 2026-04-24. Section “Summary Compensation Table” · page 48. As printed: 9,623,279. View filing ↗
  • Section 01, John Johnson. DEF 14A, filed 2026-04-24. Section “Summary Compensation Table” · page 48. As printed: 5,370,671. View filing ↗
  • Section 01, Jonathan Weinberg. DEF 14A, filed 2026-04-24. Section “Summary Compensation Table” · page 48. As printed: 2,639,664. View filing ↗
  • Section 01, Emily Rafferty. DEF 14A, filed 2026-04-24. Section “Summary Compensation Table” · page 48. As printed: 2,404,625. View filing ↗
  • Section 03, Seth Blackley PSU. DEF 14A, filed 2026-04-24. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
  • Section 03, Jonathan Weinberg PSU. DEF 14A, filed 2026-04-24. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
  • Section 03, Jonathan Weinberg RSU. DEF 14A, filed 2026-04-24. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
  • Section 03, Emily Rafferty RSU. DEF 14A, filed 2026-04-24. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
  • Section 03, Emily Rafferty PSU. DEF 14A, filed 2026-04-24. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
  • Section 03, Daniel McCarthy PSU. DEF 14A, filed 2026-04-24. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
  • Section 03, John Johnson PSU. DEF 14A, filed 2026-04-24. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
  • Section 03, Jonathan Weinberg RSU. DEF 14A, filed 2026-04-24. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
  • Section 03, Daniel McCarthy RSU. DEF 14A, filed 2026-04-24. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
  • Section 03, John Johnson RSU. DEF 14A, filed 2026-04-24. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
  • Section 03, Daniel McCarthy RSU. DEF 14A, filed 2026-04-24. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
  • Section 03, John Johnson RSU. DEF 14A, filed 2026-04-24. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
  • Section 07, pay ratio. DEF 14A, filed 2026-04-24. Section “CEO Pay Ratio”. As printed: 192.6 : 1. View filing ↗
  • Section 08, Richard Jelinek. DEF 14A, filed 2026-04-24. Section “Director Compensation”. As printed: 425,000. View filing ↗
  • Section 08, Brendan Springstubb. DEF 14A, filed 2026-04-24. Section “Director Compensation”. As printed: 373,417. View filing ↗
  • Section 08, Kim Keck. DEF 14A, filed 2026-04-24. Section “Director Compensation”. As printed: 292,500. View filing ↗
  • Section 08, Craig Barbarosh. DEF 14A, filed 2026-04-24. Section “Director Compensation”. As printed: 282,500. View filing ↗
  • Section 08, Toyin Ajayi, MD. DEF 14A, filed 2026-04-24. Section “Director Compensation”. As printed: 282,500. View filing ↗
  • Section 08, Cheryl Scott. DEF 14A, filed 2026-04-24. Section “Director Compensation”. As printed: 282,500. View filing ↗
  • Section 08, Peter Grua. DEF 14A, filed 2026-04-24. Section “Director Compensation”. As printed: 280,000. View filing ↗
  • Section 08, Russell Glass. DEF 14A, filed 2026-04-24. Section “Director Compensation”. As printed: 275,000. View filing ↗
  • Section 08, Shawn Guertin. DEF 14A, filed 2026-04-24. Section “Director Compensation”. As printed: 270,000. View filing ↗
  • Section 08, M. Bridget Duffy, MD. DEF 14A, filed 2026-04-24. Section “Director Compensation”. As printed: 0. View filing ↗
  • Section 08, Seth Blackley. DEF 14A, filed 2026-04-24. Section “Director Compensation”. As printed: 0. View filing ↗
  • Section 08, Diane Holder. DEF 14A, filed 2026-04-24. Section “Director Compensation”. As printed: 0. View filing ↗
  • Section 08, Jill Smith. DEF 14A, filed 2026-04-24. Section “Director Compensation”. As printed: 0. View filing ↗
  • Section 02, Brendan Springstubb 2026-06-04. Form 4, filed 2026-06-08. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Jill Smith 2026-06-04. Form 4, filed 2026-06-08. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Kim Keck 2026-06-04. Form 4, filed 2026-06-08. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Richard Jelinek 2026-06-04. Form 4, filed 2026-06-08. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Shawn Guertin 2026-06-04. Form 4, filed 2026-06-08. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Peter Grua 2026-06-04. Form 4, filed 2026-06-08. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Toyin Ajayi, MD 2026-06-04. Form 4, filed 2026-06-08. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Craig Barbarosh 2026-06-04. Form 4, filed 2026-06-08. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Russell Glass 2026-06-04. Form 4, filed 2026-06-08. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Aammaad Shams 2026-07-01. Form 4, filed 2026-07-06. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Daniel McCarthy 2026-07-01. Form 4, filed 2026-07-06. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Jonathan Weinberg 2026-07-01. Form 4, filed 2026-07-06. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Seth Blackley 2026-07-01. Form 4, filed 2026-07-06. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Daniel McCarthy 2026-07-01. Form 4, filed 2026-07-06. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Jonathan Weinberg 2026-07-01. Form 4, filed 2026-07-06. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Seth Blackley 2026-07-01. Form 4, filed 2026-07-06. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Daniel McCarthy 2026-08-26. Form 4, filed 2026-08-28. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 06, 2026 vote. Form 8-K, filed 2026-06-04. Item 5.07 · say-on-pay result. As reported: 88.05% (votes for as printed: 58,369,473). View filing ↗
  • Section 06, 2025 vote. Form 8-K, filed 2025-06-05. Item 5.07 · say-on-pay result. As reported: 88.41% (votes for as printed: 77,588,031). View filing ↗
  • Section 06, 2024 vote. Form 8-K, filed 2024-06-11. Item 5.07 · say-on-pay result. As reported: 94.26% (votes for as printed: 97,716,171). View filing ↗
  • Section 01 trend, Δ column (computed). Computed. Δ = current-FY total − prior-FY total per named officer.
  • Section 03b vehicle mix (computed). Computed. RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).
  • Section 09b board cost (computed). Computed. Cash 1,083,417 + equity 1,680,000 + all other 0 = 2,763,417, summed across the director compensation table rows.
  • Manhattan Associates, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-02. CEO total compensation as printed in Manhattan Associates, Inc.'s own proxy. As printed: 16,697,528. View filing ↗
  • Astrana Health, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-17. CEO total compensation as printed in Astrana Health, Inc.'s own proxy. As printed: 14,930,231. View filing ↗
  • Evolent Health (subject), Section 10b CEO total. DEF 14A, filed 2026-04-24. CEO total compensation as printed in Evolent Health's own proxy. As printed: 14,240,154. View filing ↗
  • R1 RCM Inc., Section 10b CEO total. DEF 14A, filed 2024-04-12. CEO total compensation as printed in R1 RCM Inc.'s own proxy. As printed: 14,159,376. View filing ↗
  • Pediatrix Medical Group, Inc., Section 10b CEO total. DEF 14A, filed 2026-03-27. CEO total compensation as printed in Pediatrix Medical Group, Inc.'s own proxy. As printed: 14,140,217. View filing ↗
  • HealthEquity, Inc., Section 10b CEO total. DEF 14A, filed 2026-05-13. CEO total compensation as printed in HealthEquity, Inc.'s own proxy. As printed: 13,582,105. View filing ↗
  • RadNet, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-20. CEO total compensation as printed in RadNet, Inc.'s own proxy. As printed: 12,087,934. View filing ↗
  • Premier, Inc., Section 10b CEO total. DEF 14A, filed 2024-10-21. CEO total compensation as printed in Premier, Inc.'s own proxy. As printed: 11,806,381. View filing ↗
  • Teladoc Health, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-07. CEO total compensation as printed in Teladoc Health, Inc.'s own proxy. As printed: 11,202,996. View filing ↗
  • AMN Healthcare Services, Inc., Section 10b CEO total. DEF 14A, filed 2026-03-18. CEO total compensation as printed in AMN Healthcare Services, Inc.'s own proxy. As printed: 10,669,780. View filing ↗
  • Option Care Health, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-08. CEO total compensation as printed in Option Care Health, Inc.'s own proxy. As printed: 9,266,330. View filing ↗
  • Omnicell, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-13. CEO total compensation as printed in Omnicell, Inc.'s own proxy. As printed: 7,531,852. View filing ↗
  • Surgery Partners, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-23. CEO total compensation as printed in Surgery Partners, Inc.'s own proxy. As printed: 6,083,862. View filing ↗
  • agilon Health, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-22. CEO total compensation as printed in agilon Health, Inc.'s own proxy. As printed: 5,610,878. View filing ↗
  • CorVel Corporation, Section 10b CEO total. DEF 14A, filed 2026-06-26. CEO total compensation as printed in CorVel Corporation's own proxy. As printed: 1,285,043. View filing ↗
  • Oscar Health, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-22. CEO total compensation as printed in Oscar Health, Inc.'s own proxy. As printed: 1,149,308. View filing ↗
  • Veeva Systems, Inc., Section 10b CEO total. DEF 14A, filed 2026-05-04. CEO total compensation as printed in Veeva Systems, Inc.'s own proxy. As printed: 470,833. View filing ↗
  • Section 10a, Premier, Inc. reciprocity. DEF 14A. Premier, Inc. names Evolent Health in its own disclosed peer group (read from its most recent proxy). View filing ↗
  • Section 10a, R1 RCM Inc. reciprocity. DEF 14A. R1 RCM Inc.'s most recent proxy was read; its disclosed peer group does not include Evolent Health. View filing ↗
  • Section 10a, Option Care Health, Inc. reciprocity. DEF 14A. Option Care Health, Inc.'s most recent proxy was read; its disclosed peer group does not include Evolent Health. View filing ↗
  • Section 10a, Oscar Health, Inc. reciprocity. DEF 14A. Oscar Health, Inc.'s most recent proxy was read; its disclosed peer group does not include Evolent Health. View filing ↗
  • Section 10a, RadNet, Inc. reciprocity. DEF 14A. RadNet, Inc.'s most recent proxy was read; its disclosed peer group does not include Evolent Health. View filing ↗
  • Section 10a, HealthEquity, Inc. reciprocity. DEF 14A. HealthEquity, Inc. names Evolent Health in its own disclosed peer group (read from its most recent proxy). View filing ↗
  • Section 10a, agilon Health, Inc. reciprocity. DEF 14A. agilon Health, Inc. names Evolent Health in its own disclosed peer group (read from its most recent proxy). View filing ↗
  • Section 10a, AMN Healthcare Services, Inc. reciprocity. DEF 14A. AMN Healthcare Services, Inc. names Evolent Health in its own disclosed peer group (read from its most recent proxy). View filing ↗
  • Section 10a, CorVel Corporation reciprocity. DEF 14A. CorVel Corporation's most recent proxy was read; its disclosed peer group does not include Evolent Health. View filing ↗
  • Section 10a, Surgery Partners, Inc. reciprocity. DEF 14A. Surgery Partners, Inc.'s most recent proxy was read; its disclosed peer group does not include Evolent Health. View filing ↗
  • Section 10a, Manhattan Associates, Inc. reciprocity. DEF 14A. Manhattan Associates, Inc.'s most recent proxy was read; its disclosed peer group does not include Evolent Health. View filing ↗
  • Section 10a, Teladoc Health, Inc. reciprocity. DEF 14A. Teladoc Health, Inc. names Evolent Health in its own disclosed peer group (read from its most recent proxy). View filing ↗
  • Section 10a, Omnicell, Inc. reciprocity. DEF 14A. Omnicell, Inc. names Evolent Health in its own disclosed peer group (read from its most recent proxy). View filing ↗
  • Section 10a, Veeva Systems, Inc. reciprocity. DEF 14A. Veeva Systems, Inc.'s most recent proxy was read; its disclosed peer group does not include Evolent Health. View filing ↗
Get the full report — $500